Chemistry of Materials
Article
The product (N′-(4-(tert-butyl)benzoyl)-2,3,4,5,6-pentafluorobenzo-
hydrazide) was obtained as a brown powder (9.8 g) and was used for
the next step without any further purification.
phenyl)-5-phenyl-1,3,4-oxadiazole (0.50 g, 1.60 mmol), carbazole
(0.803 g, 4.80 mmol), and potassium carbonate (2.20 g, 16.0 mmol).
The flask was evacuated and purged with nitrogen and DMSO (20
mL) was added. The reaction mixture was stirred overnight at room
temperature. Upon completion, the reaction mixture was precipitated
with water and the crude product was separated via filtration. Column
chromatography (silica gel, 10% hexanes/dichloromethane as eluent)
was performed to yield the higher Rf product 2-phenyl-5-(2,4,6-
tri(9H-carbazol-9-yl)-3,5-difluorophenyl)-1,3,4-oxadiazole as a yellow
powder, and the lower Rf product 2-phenyl-5-(2,4,5-tri(9H-carbazol-
9-yl)-3,6-difluorophenyl)-1,3,4-oxadiazole as a white crystalline
powder.
N′-(4-(tert-Butyl)benzoyl)-2,3,4,5,6-pentafluorobenzohydrazide
(9.0 g, 27 mmol) was suspended in POCl3 (50 mL). The reaction was
stirred at 100 °C (oil bath). During heating, the white solid starting
materials dissolved and a clear solution was obtained. The reaction
was monitored by thin-layer chromatography (dichloromethane as
eluting solution). After 6 h, the reaction mixture was brought to room
temperature and was carefully dropped into ice water (700 mL). A
white solid precipitated, which was collected by filtration and washed
with water. After drying, the crude product was purified by column
chromatography, eluting with dichloromethane. After evaporating
solvents, the product was recrystallized from acetone/water; a white
solid was collected by filtration and dried under vacuum (8.5 g, 84%,
two steps).
2,4,6CzDPO. Yield: 0.226 g (19%). 1H NMR (500 MHz, CDCl3):
δ 8.19 (d, J = 4 Hz, 2H), 8.11 (d, J = 8 Hz, 4H), 7.58 (t, J = 8 Hz,
2H), 7.51 (t, J = 8 Hz, 4H), 7.46−7.37 (m, 8H), 7.33 (t, J = 8 Hz,
4H), 7.17 (t, J = 8 Hz, 2H), 6.89 (d, J = 8 Hz, 2H). 13C{1H} NMR
(125 MHz, CDCl3): δ 164.59, 156.65 (t, JCF = 2.5 Hz), 156.41 (dd,
1JCF = 268 Hz, JCF = 5 Hz), 140.90, 139.49, 131.64, 128.46, 126.67,
1H NMR (400 MHz, CDCl3): δ 8.06 (d, J = 8 Hz, 2H), 7.57 (d, J =
8 Hz, 2H), 1.37 (s, 9H). 13C{1H} NMR (125 MHz, CDCl3): δ
165.83, 156.22 154.40 (m), 145.17 (dm, 1JCF = 256 Hz), 143.21 (dtt,
126.62, 126.54, 126.35, 124.39, 124.04, 123.66 (dd, JCF = 14 Hz, JCF
=
1
1JCF = 259 Hz, JCF = 13, 5 Hz), 138.13 (dm, JCF = 252 Hz), 127.08,
5 Hz), 122.18, 121.60, 120.69, 119.84 (t, JCF = 15 Hz), 109.89,
108.96. 19F NMR (470 MHz, CDCl3): δ −113.00 (s). HRMS
(MALDI, m/z): Calcd for C50H29N5OF2 (M+), 754.2413; Found,
754.2410. Anal. Calcd for C50H29N5OF2: C, 79.67; H, 3.88; N, 9.29.
Found: C, 79.75; H, 3.73; N, 9.45.
126.22, 101.00 (td, JCF = 15, 5 Hz), 35.16, 31.05. 19F NMR (376.5
MHz, CDCl3, CF3COOH): δ −135.45 (m, 2F), −147.04 (m, 1F),
−159.56 (m, 2F). HRMS (EI, m/z): Calcd for C18H13N2OF5 (M+),
368.0948; Found, 368.0944.
2,4,5CzDPO. Yield: 0.273 g (23%). 1H NMR (500 MHz, CDCl3):
δ 8.12 (d, J = 4 Hz, 2H), 7.80−7.78 (m, 2H), 7.76−7.74)m, 2H), 7.52
(t, J = 8 Hz, 2H), 7.44 (d, J = 8 Hz, 2H), 7.41 (d, J = 8 Hz, 1H), 7.35
(t, J = 8 Hz, 2H), 7.28 (t, J = 8 Hz, 2H), 7.24−7.21 (m, 4H), 7.15−
7.08 (m 10H). 13C{1H} NMR (125 MHz, CDCl3): δ 165. 05, 156.11
2-(4-(9H-Carbazol-9-yl)-2,3,5,6-tetrafluorophenyl)-5-phen-
yl-1,3,4-oxadiazole (CzDPO). In a round-bottom flask, 2-(penta-
fluorophenyl)-5-phenyl-1,3,4-oxadiazole (1.03 g, 3.30 mmol), carba-
zole (0.570 g, 3.41 mmol), and potassium carbonate (4.42 g, 32.0
mmol) were placed under vacuum and then under nitrogen. DMSO
(20 mL) was added and the reaction mixture was stirred overnight at
room temperature. The reaction progress was monitored via thin-layer
chromatography. Upon completion, the mixture was precipitated with
water and the crude product was collected via filtration. Column
chromatography (9:1 ethyl acetate/hexanes as eluent) yielded the
1
(q, JCF = 2.5 Hz), 154.22 (dd, JCF = 263 Hz, JCF = 3.8 Hz), 153.27
1
(dd, JCF = 255 Hz, JCF = 3.8 Hz), 140.76, 138.58, 138.43, 131.91,
128.71, 128.12 (dd, JCF = 14 Hz, JCF = 3.8 Hz), 128.76, 126.75,
125.73, 125.71, 125.10 (dd, JCF = 15 Hz, JCF = 3.8 Hz), 124.14,
124.13, 124.05, 122.45, 121.26, 121.15, 121.03, 120.62, 120.04,
120.02, 114.01 (d, JCF = 14 Hz), 109.91, 109.83, 109.35. 19F NMR
(470 MHz, CDCl3): δ −111.64 (d, J = 14 Hz, 1F), −120.54 (d, J = 14
Hz, 1F). HRMS (MALDI, m/z): Calcd for C50H29N5OF2 (M+),
754.2413; Found, 753.2347. Anal. Calcd for C50H29N5OF2: C, 79.67;
H, 3.88; N, 9.29. Found: C, 79.60; H, 4.00; N, 9.32.
1
higher Rf fluorescent product as a white powder (0.819 g, 54%). H
NMR (500 MHz, CDCl3): δ 8.21 (d, J = 6.5 Hz, 2H), 8.16 (d, J = 7.5
Hz, 2H), 7.63−7.57 (m, 3H), 7.50 (t, J = 7.5 Hz, 2H), 7.39 (t, J = 8
Hz, 2H), 7.22 (d, J = 8 Hz, 2H). 13C{1H} (125 MHz, CDCl3): δ
165.84, 155.16, 145.33 (ddt, 1JCF = 260 Hz, JCF = 14 Hz, JCF = 4 Hz),
144.14 (ddt, 1JCF = 255 Hz, JCF = 14 Hz, JCF = 4 Hz), 139.40, 132.50,
129.27, 127.30, 126.66, 124.35, 123.01, 121.65, 120.61, 119.83 (t, JCF
= 14 Hz), 109.94, 104.51 (t, JCF = 14 Hz). 19F NMR (470 MHz,
CDCl3): δ −134.94 (m, 2F), −140.38 (m, 2F). HRMS (EI, m/z):
Calcd for C26H13N3OF4 (M+), 459.0995; Found, 459.0995.
2-Phenyl-5-(2,3,4,6-tetra(9H-carbazol-9-yl)-5-fluorophenyl)-
1,3,4-oxadiazole (2,3,4,6CzDPO). A solution of 2-(pentafluoro-
phenyl)-5-phenyl-1,3,4-oxadiazole (1.0 g, 3.2 mmol), carbazole (2.13
g, 12.7 mmol), and potassium carbonate (7.0 g, 50. mmol) in DMSO
(20 mL) was stirred at room temperature for 27 h under nitrogen.
Water (100 mL) was added and a pale yellow solid was obtained. The
solid product was collected by filtration, and washed with water. After
drying, the crude product was purified by column chromatography
using dichloromethane/hexane (8:2) as eluent. After removal of
solvent, the yellow solid was dissolved in dichloromethane, and
methanol (100 mL) was added. Dichloromethane was removed and a
pale-yellow solid was recrystallized from methanol solution. The solid
product was collected by filtration. After drying under vacuum, the
2-(2,4-Di(9H-carbazol-9-yl)-3,5,6-trifluorophenyl)-5-phenyl-
1,3,4-oxadiazole (2,4CzDPO). In a round-bottom flask, 2-(penta-
fluorophenyl)-5-phenyl-1,3,4-oxadiazole (0.482 g, 1.54 mmol),
carbazole (0.408 g, 2.44 mmol), and potassium carbonate (3.5 g, 25
mmol) were placed under vacuum and then under nitrogen. DMSO
(10 mL) was added and the reaction mixture was stirred overnight at
room temperature. Upon completion, the mixture was precipitated
with water and the crude product was separated via filtration. Column
chromatography (10% ethyl acetate in hexanes as eluent) yielded the
1
product was obtained (1.6 g, 55%). H NMR (500 MHz, CDCl3): δ
1
8.09 (d, J = 8 Hz, 2H), 7.74−7.73 (m, 2H), 7.62 (d, J = 8 Hz, 2H),
7.49−7.44 (m, 4H), 7.39 (d, J = 8 Hz, 2H), 7.32−7.27 (m, 3H),
7.23−7.20 (m, 4H), 7.15−7.06 (m, 8H), 7.03 (t, J = 8 Hz, 2H),
6.85−6.80 (m, 4H), 6.73 (t, J = 8 Hz, 2H). 13C{1H} NMR (125
MHz, CDCl3): δ 164.30, 157.14 (d, J = 4 Hz), 156.39 (d, 1JCF = 261
Hz), 140.95, 139.71, 138.72, 138.12, 136.64 (d, J = 2.5 Hz), 134.13
(d, J = 4 Hz), 131.47, 129.35 (d, J = 14 Hz), 128.37, 127.16 (d, J = 15
Hz), 126.95 (d, J = 1 Hz), 126.55, 126.48, 125.61, 125.55, 124.68,
124.14, 124.01, 123.72, 122.26, 121.04, 120.97, 120.70, 120.56,
120.47, 120.04, 119.54, 110.05, 109.30, 109.28. 19F NMR (470 MHz,
CDCl3): δ −113.83 (s). HRMS (MALDI, m/z): Calcd for
C67H37N6OF (M+) 900.3013; Found 900.3005. Anal. Calcd for
C67H37N6OF: C, 82.65; H, 4.14; N, 9.33. Found: C, 82.43; H, 4.08;
N, 9.32.
product as a white powder (0.177 g, 19%). H NMR (500 MHz,
CDCl3): δ 8.16 (d, J = 5 Hz, 2H), 8.06 (d, J = 10 Hz, 2H), 7.52 (t, J =
10 Hz, 2H), 7.44−7.38 (m, 5H), 7.31−7.28 (m, 4H), 7.25 (t, J = 10
Hz, 2H), 7.20 (d, J = 10 Hz, 2H), 7.13 (d, J = 10 Hz, 2H). 13C{1H}
1
NMR (125 MHz, CDCl3): δ 165.09, 155.69, 152.77 (d, JCF = 259
Hz), 147.97 (dd, 1JCF = 262 Hz, JCF = 16 Hz), 146.93 (dd, 1JCF = 265
Hz, JCF = 16 Hz) 140.83, 139.46, 131.99, 128.71, 126.76, 126.75,
126.69, 124.38, 123.95, 122.30, 121.64, 121.35, 121.14, 120.66,
120.58, 119.84 (t, JCF = 15 Hz), 114.47 (d, JCF = 11 Hz), 114.42,
109.93, 109.07. 19F NMR (470 MHz, CDCl3): δ −120.34 (d, J = 14
Hz, 1F), −131.78 (d, J = 24 Hz, 1F), −131.89 (dd, J = 24 Hz, 14 Hz,
1F). HRMS (ESI, m/z): Calcd for C38H22N4OF3 (M+), 607.174;
Found, 607.1723.
2-Phenyl-5-(2,4,6-tri(9H-carbazol-9-yl)-3,5-difluorophenyl)-
1,3,4-oxadiazole (2,4,6CzDPO) and 2-Phenyl-5-(2,4,5-tri(9H-
carbazol-9-yl)-3,6-difluorophenyl)-1,3,4-oxadiazole (2,4,
5CzDPO). To a round-bottom flask were added 2-(pentafluoro-
2-(4-(tert-Butyl)phenyl)-5-(2,3,4,5,6-penta(9H-carbazol-9-
yl)phenyl)-1,3,4-oxadiazole (2,3,4,5,6CzDPO). A solution of 2-
(4-(tert-butyl)phenyl)-5-(pentafluorophenyl)-1,3,4-oxadiazole (0.20
C
Chem. Mater. XXXX, XXX, XXX−XXX